Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58.

Avivit CahnStephen D WiviottOfri MosenzonErica L GoodrichSabina A MurphyIlan YanuvAliza RozenbergDeepak L BhattLawrence A LeiterDarren K McGuireJohn P H WildingIngrid A M Gause-NilssonAnna Maria LangkildeMarc S SabatineItamar Raz

Published in: Diabetes care (2022)

Higher HbA1c levels were associated with greater cardiovascular and renal risk, particularly in the MRF population, yet the benefits of dapagliflozin were observed in all subgroups irrespective of baseline HbA1c, including patients with HbA1c <7%.

Keyphrases

type diabetes
metabolic syndrome